Advertisement

Anticoagulation and Regional Anesthesia Concerns

  • Rinoo Shah
  • Alan David Kaye
  • Adam Kaye
  • Jeffrey Y. Tsai
Chapter

Abstract

Interventional pain management is an emerging specialty that uses procedures to diagnose and treat chronic pain. Most of these procedures are performed percutaneously and carry a risk of bleeding [1]. Regional anesthesia similarly uses percutaneous injection techniques for surgery, perioperatively, and postoperative analgesia. Patients undergoing these treatments may be receiving exogenous anticoagulants or have impaired hemostasis.

Keywords

Regional Anesthesia Bleeding Risk Epidural Catheterization Epidural Hematoma Neuraxial Anesthesia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Raj PP, Shah RV, Kaye AD, Denaro S, Hoover JM. Bleeding risk in interventional pain practice: assessment, management, and review of the literature. Pain Physician. 2004;7(1):3–51.PubMedGoogle Scholar
  2. 2.
    Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy (the third ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med. 2010;35:64–101.PubMedCrossRefGoogle Scholar
  3. 3.
    Boswell MV, Shah RV, Everett CR, Sehgal N, McKenzie Brown AM, Abdi S, et al. Interventional techniques in the management of chronic spinal pain:evidence-based practice guidelines. Pain Physician. 2005;8(1):1–47.PubMedGoogle Scholar
  4. 4.
    Petrovitch CT, Drummond JC. Hemotherapy and hemostasis. In: Barash PG, Cullen BF, Stoelting RK, editors. Clinical anesthesia. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. p. 201–42.Google Scholar
  5. 5.
    Meisenberg G, Simmons WH. Principles of medical biochemistry. St Louis, MO: Mosby Inc.; 1998. p. 511–45.Google Scholar
  6. 6.
    Guyton AC, Hall JE. Hemostasis and blood coagulation. In: Guyton AC, Hall JE, editors. Textbook of medical physiology. 10th ed. Philadelphia, PA: WB Saunders Company; 2001. p. 419–29.Google Scholar
  7. 7.
    Ellison N. Diagnosis and management of bleeding disorders. Anesthesiology. 1977;47:171–80.PubMedCrossRefGoogle Scholar
  8. 8.
    Mannucci PM, Federici AB. Best management of inherited von Willebrand disease. Pract Res Clin Haematol. 2001;14:455–62.CrossRefGoogle Scholar
  9. 9.
    Cotran RS, Kumar V, Collins T. Red cells bleeding disorders: Robbins, pathology of disease. 6th ed. Philadelphia, PA: WB Saunders Company; 1999. p. 601–43.Google Scholar
  10. 10.
    Mannucci PM, Tuddenham EG. The hemophilias-from royal genes to gene therapy. N Engl J Med. 2001;344:1773–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Kane AB, Kumar V. Environmental and nutritional pathology. In: Cotran RS, Kumar V, Collins T, editors. Robbins, pathology of disease. 6th ed. Philadelphia, PA: WB Saunders Company; 1999. p. 403–57.Google Scholar
  12. 12.
    Sallah S, Bobzien W. Bleeding problems in patients with liver disease. Ways to manage the many hepatic effects on coagulation. Postgrad Med. 1999;106:187–90,193–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Al W, Al S. Uremic bleeding: pathogenesis and therapy. Am J Med Sci. 1998;316:94–104.CrossRefGoogle Scholar
  14. 14.
    Horlocker TT, Wedel DJ, Schroeder DR, et al. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg. 1995;80:303–9.PubMedGoogle Scholar
  15. 15.
    Cronberg S, Wallmark E, Soderberg I. Effect on platelet aggregation of oral administration of 10 non-steroidal analgesics on humans. Scand J Haematol. 1984;33:155–9.PubMedCrossRefGoogle Scholar
  16. 16.
    CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemicevents (CAPRIE). Lancet. 1996;348:1329–39.CrossRefGoogle Scholar
  17. 17.
    O’Neill WW, Serruys P, Knudtson M, et al. Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events. N Engl J Med. 2000;342:1316–24.PubMedCrossRefGoogle Scholar
  18. 18.
    Xi M, Beguin S. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients. Thromb Haemost. 1989;62:788–91.PubMedGoogle Scholar
  19. 19.
    Hirsh J, Raschke R, Warkentin TE, et al. Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 1995;108:258S–75S.PubMedCrossRefGoogle Scholar
  20. 20.
    Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001;119:S64–94.CrossRefGoogle Scholar
  21. 21.
    Kaye AD, Clarke RC, Sabar R, et al. Herbal medicines: current trends in anesthesiology practice-a hospital survey. J Clin Anesth. 2000;12:468–71. Important review about the risks associated with herbal medications.PubMedCrossRefGoogle Scholar
  22. 22.
    Tam NL, Pac-Soo C, Pretorius PM. Epidural haematoma after a combined spinal-epidural anaesthetic in a patient treated with clopidogrel and dalteparin. Br J Anaesth. 2006;96(2):262–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990–1999. Anesthesiology. 2004;101(4):950–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Ho AM, Chung DC, Joynt GM. Neuraxial blockade and hematoma in cardiac surgery: estimating the risk of a rare adverse event that has not (yet) occurred. Chest. 2000;117(2):551–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Chaney MA. Intrathecal and epidural anesthesia and analgesia for cardiac surgery. Anesth Analg. 2006;102(1):45–64.PubMedCrossRefGoogle Scholar
  26. 26.
    Christie-Taylor GA, McAuliffe GL. Epidural placement in a patient with undiagnosed acquired haemophilia from factor VIII inhibitor. Anaesthesia. 1999;54:367–71.PubMedCrossRefGoogle Scholar
  27. 27.
    Kang SB, Rumball KM, Ettinger RS. Continuous axillary brachial plexus analgesia in a patient with severe hemophilia. J Clin Anesth. 2003;15:38–40.PubMedCrossRefGoogle Scholar
  28. 28.
    Stedeford JC, Pittman JA. Von Willebrand’s disease and neuroaxial anaesthesia. Anaesthesia. 2000;55:1228–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Milaskiewicz RM, Holdcroft A, Letsky E. Epidural anaesthesia and Von Willebrand’s disease. Anaesthesia. 1990;45:462–4.PubMedCrossRefGoogle Scholar
  30. 30.
    Dunn D, Dhopesh V, Mobini J. Spinal subdural hematoma: a possible hazard of lumbar puncture in an alcoholic. JAMA. 1979;241:1712–3.PubMedCrossRefGoogle Scholar
  31. 31.
    Grejda S, Ellis K, Arino P. Paraplegia following spinal anesthesia in a patient with chronic renal failure. Reg Anesth. 1989;14:155–7.PubMedGoogle Scholar
  32. 32.
    Levine M, Raskob G, Landefeld S, et al. Hemorrhagic complications of anticoagulant therapy. Chest. 2001;119:108S–21S.PubMedCrossRefGoogle Scholar
  33. 33.
    Stafford-Smith M. Impaired haemostasis and regional anaesthesia. Can J Anaesth. 1996;43:R129–41.PubMedCrossRefGoogle Scholar
  34. 34.
    Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg. 1994;79:1165–77. Important paper that estimates the risks of hematomas associated with anticoagulants and epidural anesthesia.PubMedCrossRefGoogle Scholar
  35. 35.
    Maier C, Gleim M, Weiss T, Stachetzki U, Nicolas V, Zenz M. Severe bleeding following lumbar sympathetic blockade in two patients under medication with irreversible platelet aggregation inhibitors. Anesthesiology. 2002;97:740–3. Important paper recognizing that even non-spinal injections pose a significant hazard with respect to bleeding.PubMedCrossRefGoogle Scholar
  36. 36.
    Benzon HT, Wong HY, Siddiqui T, et al. Caution in performing epidural injections in patients on several antiplatelet drugs. Anesthesiology. 1999;91:1558–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Wille-Jorgensen P, Jorgensen LN, Rasmussen LS. Lumbar regional anesthesia and prophylactic anticoagulant therapy: is the combination safe? Anaesthesia. 1991;46:623–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Lumpkin MM. FDA public health advisory. Anesthesiology. 1998;88:27A–8A.PubMedCrossRefGoogle Scholar
  39. 39.
    Gogarten W, Van Aken H, Wulf H, et al. Para-spinal regional anesthesia and prevention of thromboembolism/ anticoagulation: recommendations of the German Society of Anesthesiology and Intensive Care Medicine. Anasthesiol Intensivmed Notfallmed Schmerzther. 1997;38:623–8.Google Scholar
  40. 40.
    Layton KF, Kallmes DF, Horlocker TT. Recommendations for anticoagulated patients undergoing image-guided spinal procedures. AJNR Am J Neuroradiol. 2006;27(3):468–70.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Rinoo Shah
    • 1
  • Alan David Kaye
    • 2
    • 3
    • 4
  • Adam Kaye
    • 5
  • Jeffrey Y. Tsai
    • 6
  1. 1.Department of AnesthesiologyGuthrie ClinicHorseheadsUSA
  2. 2.Interventional Pain ManagementUniversity Hospital and Ochsner Kenner HospitalKennerUSA
  3. 3.Department of AnesthesiologyLouisiana State University School of MedicineNew OrleansUSA
  4. 4.Department of PharmacologyLouisiana State University School of MedicineNew OrleansUSA
  5. 5.Department of Pharmacy Practice, Thomas J. Long School of Pharmacy and Health SciencesUniversity of the PacificStocktonUSA
  6. 6.Medical School at Western U of Health Sciences2011 Western University of Health SciencesNew OrleansUSA

Personalised recommendations